Company Filing History:
Years Active: 2011-2012
Title: Stephanie L Abraham: Innovator in Monoclonal Antibodies
Introduction
Stephanie L Abraham is a prominent inventor based in Clancy, Montana, known for her significant contributions to the field of monoclonal antibodies. With a total of 3 patents, her work focuses on the detection and treatment of pancreatic conditions, showcasing her dedication to advancing medical science.
Latest Patents
Abraham's latest patents involve isolated monoclonal antibodies that specifically bind to cell surface antigens expressed on human pancreatic endocrine and exocrine cells. These antibodies are designed to detect and isolate pancreatic cells, which can be crucial for diagnosing conditions such as diabetes and pancreatic tumors. The patents also describe methods for treating pancreatic tumors using these antibodies, which can be conjugated to effector molecules or detectable markers for enhanced functionality.
Career Highlights
Stephanie L Abraham is affiliated with Oregon Health & Science University, where she continues her research and development in the field of biomedical science. Her innovative work has the potential to impact the diagnosis and treatment of pancreatic diseases significantly.
Collaborations
Abraham has collaborated with notable colleagues, including Markus Grompe and Philip R Streeter, contributing to a rich environment of research and innovation.
Conclusion
Stephanie L Abraham's work in monoclonal antibodies represents a significant advancement in medical research, particularly in the context of pancreatic health. Her contributions are paving the way for new diagnostic and therapeutic approaches in the field.